Business
MindMed Raises $19.5 Million // What Does This Mean for MMEDF/MMED? [Plus Upcoming Market CRASH?]
VideosHey guys! Today's episode is more of a fast rant on the recent press release about MindMed raising ANOTHER $19.5M from Canaccord Genuity Corp, on a deal that is set to close tomorrow, March 9th.
Here, I'm discussing:
1. The number MindMed shares being sold and their respective price;
2.Why is MindMed doing this?
3. Potential short term and long term effects on MMED's stock price
4. Nasdaq uplisting?
5. Market crash thoughts
I hope you guys found some value in this and I'll keep you posted for more changes!
Remember to Like, Subscribe, and SMASH that notifications bell to keep up to date on all the latest Psychedelic Stocks news!
Follow us on social media! 🙌
Instagram: @psychedelicinvestor
Facebook: @thepsychedelicinvestor
Music: www.bensound.com
DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments.
#MindMed #MindmedStock #MMEDNews
Defiance Just Launched the World’s Second Psychedelics-Focused ETF
BusinessDefiance has launched the world's second psychedelics-focused ETF as investing in psychedelic therapy and treatment accelerates.
This Week in Psychedelic Stocks [UPDATES ON MINDMED (MMED/MMEDF/MMQ) CMPS, MYCOF, NUMI & ATAI, TRIP]
VideosIn today's episode of "This Week in Psychedelic Stocks", we'll see some news on MindMed (MMED / MMEDF/MMQ), Compass Pathways (CMPS), Atai Life Sciences, Mydecine (MYCO/MYCOF), Numinuss Wellness (NUMI), and Red Light Holland (TRIP).
We will cover the latest developments in the field writ large.
This means we will cover any stories that affect the all the companies in this field, as well as company specific developments.
Time Stamps
0:00 - Intro
0:35 - Imperial College Of London results of Study the effects of microdosing psychedelics and their impact on the psychedelic industry
5:45 - 15 Canadian healthcare professionals begin a historic psilocybin training program
6:55 - Chief of the Defense Force, Chris Barrie, is calling for psychedelic compounds like psilocybin and MDMA to be rescheduled
8:31 - A smartphone app called promises to induce a psychedelic like state (FUN)!
10:58 - MindMmed Stock News ( MMED/MMEDF/MMQ) and Company Updates
13:33 - Compass Pathways (CMPS) Stock News and Company Updates
15:22 - Atai Life Sciences Company News and IPO Speculation
16:42 - Numinus (NUMI) Stock News & 3 Company Updates
19:30 -Red Light Holland (TRIP) Stock News & Very Interesting Company Update
20:52 - Mydecine (MYCO/MYCOF) Stock News & Updates
So this is it for This Week in Psychedelic Stocks fellow psychedelic investors!
I hope you guys found some value in this and I'll keep you posted for more changes!
Remember to Like, Subscribe, and SMASH that notifications bell to keep up to date on all the latest Psychedelic Stocks news!
Follow us on social media! 🙌
Instagram: @psychedelicinvestor
Facebook: @thepsychedelicinvestor
Music: www.bensound.com
DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments.
#MindMed #MindmedStock #PsychedelicStocks
Psychedelic Business News Spotlight: March 5, 2021
BusinessThis week in psychedelic business news: two companies enter the Canadian Stock Exchange, AI comes to psychedelic treatment, and psilocybin comes to Brazil.
Psychedelic Biotech Company Atai Life Sciences Valued At $2 Billion
BusinessBiotech company Atai Life Sciences has earned a $2 billion valuation for its work in developing psychedelic treatments for mental health issues.
The Mainstream Media GETS Psychedelic Stocks [Like MMEDF, CMPS, EHVVF & FTRPF]
VideosHello psychedelic investors! Today’s episode will be a little different. We will discuss the recent media coverage of psychedelic stocks and its role in psychedelic inspired companies' future.
It appears that the mainstream media understands the potential for psychedelic stocks to disrupt the pharmaceutical Industry. Now understanding what this means, and its implications is extremely important for retail investors like you and me.
We'll also zoom into one piece of media about MindMed (MMED/MMEDF) and Compass Pathways (CMPS), and explore how it hits the nail on the head.
We are going to do this because one, it’s a good article that I wanted to share with you
And two, it exemplifies my point that the mainstream understands the potential here, and might actually be on the right side of history.
P.S. I mention in the video that the article I'm discussing is by Yahoo Finance. It turns out the article is from OTC stock review.
For those interested in reading the entire article: https://ca.movies.yahoo.com/264-million-reasons-psychedelic-stocks-133000885.html
Time Stamps
0:00 - Intro
3:10 - Media Coverage on Tesla & Psychedelic Stocks
6:36 - Benefits of the media covering Psychedelic Companies like (MMEDF & CMPS)
8:05 - Influence on stock valuations and stealth investors
10:57 - 264 Million Reasons Why Psychedelic Stocks Have More Room To Grow
I hope you guys found some value in this and I'll keep you posted for more changes!
Remember to Like, Subscribe, and SMASH that notifications bell to keep up to date on all the latest Psychedelic Stocks news!
Follow us on social media! 🙌
Instagram: @psychedelicinvestor
Facebook: @thepsychedelicinvestor
Music: www.bensound.com
DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments.
#MindMed #MindmedStock #PsychedelicStocks
This Week in Psychedelic Stocks [Big UPDATES ON MMEDF, CMPS, FTRPF, and ATAI]
VideosHello Psychedelic Investors! In this new segment entitled "This Week in Psychedelic Stocks", we'll see some news on MindMed (MMED / MMEDF), Compass Pathways (CMPS), Atai Life Sciences, and Field Trip Health (FTRPF/ FTRP).
We will cover the latest developments in the field writ large,
This means we will cover any stories that affect the all the companies in this field, as well as company specific developments.
Time Stamps
0:00 - Intro
0:56 - California Legalizing Psychedelics?
2:09 - Texas Legalizing Psychedelics?
3:33 - STOP LICKING TOADS DUDE
4:05 - MindMed Stock Updates (MMED / MMEDF)
9:13 - Compass Pathways Stock Updates (CMPS)
13:25 - Atai Life Sciences Update
17:05 - Field Trip Health Stock Updates (FTRPF/ FTRP)
I hope you guys found some value in this and I'll keep you posted for more changes!
Remember to Like, Subscribe, and SMASH that notifications bell to keep up to date on all the latest Psychedelic Stocks news!
Follow us on social media! 🙌
Instagram: @psychedelicinvestor
Facebook: @thepsychedelicinvestor
Music: www.bensound.com
DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments.
#MindMed #MindmedStock #PsychedelicStocks
Psychedelic Business News Spotlight: February 26, 2021
BusinessThis week in psychedelic business news, Field Trip upsizes its bought deal, psilocybin truffles head to Brazil, another company goes public, and more.